![JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/7/865/F1.large.jpg)
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
![Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists](https://www.frontiersin.org/files/Articles/437721/fphar-10-00212-HTML/image_m/fphar-10-00212-g001.jpg)
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
![Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00738/article_deploy/html/images/pharmaceuticals-14-00738-g001.png)
Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases | Journal of Medicinal Chemistry
View of JANUS KINASE ENZYME (JAK) INHIBITORS AND RHEUMATOID ARTHRITIS: A REVIEW OF THE LITERATURE | International Journal of Current Pharmaceutical Research
![Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/a707b3e7-a92c-4a8e-b0e3-0112c506c162/gr1.jpg)
Treating inflammation with the Janus Kinase inhibitor CP-690,550: Trends in Pharmacological Sciences
![Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00048/article_deploy/html/images/pharmaceuticals-15-00048-ag.png?1640942350)
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
![Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/1/71/F1.large.jpg)
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases
![Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816307137-fx1.jpg)